Related Experiment Video

Updated: Aug 14, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cell pharmacogenomics: a reality check on stem cell therapy

Sharmila A Bapat1, Gyan C Mishra

  • 1National Centre for Cell Science, Ganeshkhind, Pune 411007, India. sabapat@nccs.res.in

Current Opinion in Molecular Therapeutics
|December 24, 2005
PubMed

Insights

Predicting stem cell therapy success requires understanding donor-host interactions beyond genetics. Developing guidelines for pharmacogenetics and cellular factors will personalize treatments and improve long-term outcomes.

Area of Science:

  • Regenerative Medicine
  • Pharmacogenomics
  • Immunology

Background:

  • Stem cell therapies show promise but often fail long-term.
  • Current understanding of failure factors is limited.
  • Classical pharmacogenomics doesn't fully address cell therapy complexity.

Purpose of the Study:

  • To address the lack of resolution in long-term stem cell therapy failures.
  • To propose a framework for individualizing stem cell treatments.
  • To integrate genetic and cellular factors for better therapeutic outcomes.

Main Methods:

  • Reviewing existing literature on stem cell therapy outcomes.
  • Analyzing the role of pharmacogenetics in predicting treatment response.
  • Investigating donor-host cellular interactions and adaptability.
  • Proposing the development of comprehensive guidelines.

Main Results:

  • Identification of key factors contributing to stem cell therapy failure.
  • Highlighting the need for a multi-dimensional approach beyond genetics.
  • Emphasizing the importance of host-donor cell interactions.
  • Suggesting the use of larger datasets and prospective studies.

Conclusions:

  • Stem cell therapy individualization requires considering both pharmacogenetic and donor/host cellular factors.
  • Developing concise guidelines based on these factors is crucial.
  • Prospective studies utilizing larger datasets are needed to refine these guidelines and improve long-term therapeutic success.

More Related Videos

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation11:38

A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation

Published on: October 4, 2024

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...